Physician profile
Donald E Fowler
NPI 1912167180
$9,135.86
in general payments reported to CMS, 2019-2025
12 companies · $1,458 in 2025
The $1,458 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,721 · 2020: $1,564 · 2021: $1,713 · 2022: $298 · 2023: $425 · 2024: $958 · 2025: $1,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,528 · Travel and Lodging: $1,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,527.76 |
| Travel and Lodging | $1,312.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,627.54 | 2019-2025 | |
| Smith+Nephew, INC. | $2,302.73 | 2019-2025 | Real Intelligence, Journey II, Pico 14 |
| United Orthopedics LLC | $1,396.35 | 2021-2025 | |
| Becton, Dickinson and Company | $192.68 | 2024 | Arista Ah Flexitip |
| Rti Surgical, INC | $150.00 | 2021 | |
| Depuy Synthes Sales INC. | $135.84 | 2020-2022 | |
| Encore Medical, LP | $124.32 | 2019 | |
| Anika Therapeutics, INC. | $81.37 | 2023 | Tactoset, Twist, Atlas |
| Ermi LLC | $65.75 | 2023-2025 | |
| Bioventus LLC | $25.20 | 2019 | |
| Medtronic, INC. | $21.53 | 2024 | Intellis Adaptivestim |
| Amarin Pharma, INC. | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.